We observed changes in the composition of pDCs, CD8+ T cells and CD4+ T cells, along with the emergence of plasmablasts in moderate and severe COVID-19 patients, a feature no longer observed in convalescent patients. This evidence concerns the gene CD4 and COVID-19.